Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 1/20 | 0.49 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.49 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.49 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.45 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.44 |
| ▸ | TLR2 | O60603 | 3/20 | 0.43 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3588065 | 0.95 | HDAC1 (0.52) | HDAC4HDAC1HDAC6EPHX1MDM2 | |
| SCHEMBL29653644 | 0.87 | TLR2 (0.52) | HDAC4HDAC1HDAC6MDM2TLR2 | |
| SCHEMBL29383813 | 0.84 | MDM2 (0.57) | MDM2TLR2KMT2A | |
| SCHEMBL30645673 | 0.84 | MDM2 (0.57) | MDM2TLR2KMT2A | |
| SCHEMBL29362665 | 0.84 | MDM2 (0.57) | MDM2TLR2KMT2A | |
| SCHEMBL30385460 | 0.84 | MDM2 (0.57) | MDM2TLR2KMT2A | |
| SCHEMBL30385918 | 0.84 | MDM2 (0.49) | MDM2TLR2TLR1KMT2A | |
| SCHEMBL14039221 | 0.84 | MDM2 (0.57) | MDM2TLR2KMT2A | |
| SCHEMBL4612512 | 0.84 | MDM2 (0.57) | MDM2TLR2KMT2A | |
| SCHEMBL4612515 | 0.84 | MDM2 (0.57) | MDM2TLR2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100048549-A1 | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 | Wurster, Siegfried (FI) | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048549-A1 | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 | SSTR1, SSTR4, SSTR3 | HDAC4 1252/4885HDAC1 2227/4885HDAC6 3041/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.